Pharmaceutical - Endo Health Solutions

Filter

Current filters:

Endo Health Solutions

Popular Filters

Endo agrees $193 million settlement with US Justice Dept over Lidoderm

23-02-2014

US drugmaker Endo Health Solutions and its subsidiary Endo Pharmaceuticals have agreed to pay $192.7…

Endo Health SolutionsFinancialLegalLidodermMarkets & MarketingNeurologicalPharmaceutical

NuPathe accepts Teva’s higher counter bid, rejecting Endo offer

21-01-2014

Israel-based Teva Pharmaceutical Industries seems set to bag ownership of US drugmaker NuPathe), which…

Endo Health SolutionsMergers & AcquisitionsNeurologicalNuPathePharmaceuticalTeva Pharmaceutical IndustriesZecuity

Endo divests remainder of HealthTronics for up to $130 million

09-01-2014

Endo Health Solutions says it has entered into a definitive agreement to sell its HealthTronics business…

Endo Health SolutionshealthTronicsMergers & AcquisitionsPharmaceutical

NuPathe receives counter offer from Teva topping Endo bid

09-01-2014

US drugmaker NuPathe – currently the subject of a takeover bid from USA-based Endo Health Solutions…

Endo Health SolutionsMergers & AcquisitionsNuPathePharmaceuticalTeva Pharmaceutical Industries

NuPathe rockets on news of takeover by Endo Health

NuPathe rockets on news of takeover by Endo Health

16-12-2013

In a third take-over deal announced this year, USA-based specialty health care company Endo Health Solutions…

Endo Health SolutionsMergers & AcquisitionsNeurologicalNuPathePharmaceuticalZecuity

Endo to acquire Paladin Labs in $1.6 billion deal

Endo to acquire Paladin Labs in $1.6 billion deal

06-11-2013

Shares of Endo Health Solutions leapt 29% to $56.22 by close of trading on November 5, after the company…

Endo Health SolutionsFinancialMergers & AcquisitionsPaladin LabsPharmaceutical

Endo Health expends $225 million on generic acquisition

29-08-2013

USA-based specialty health care company Endo Health Solutions (Nasdaq: ENDP) says that that its Qualitest…

Boca PharmacalEndo Health SolutionsGenericsMergers & AcquisitionsPharmaceutical

Endo Pharma gets CTL from FDA relating to testosterone drug Aveed

31-05-2013

response letter (CRL) regarding the New Drug Application (NDA) for subsidiary Endo Pharmaceuticals' long-acting…

AveedEndo Health SolutionsEndo PharmaceuticalsMen's HealthNorth AmericaPharmaceuticalRegulationTestosterone

US FDA to allow generic copies of Endo's Opana

13-05-2013

Endo Health Solutions (Nasdaq: ENDP) announced Friday (May 10) that the US Food and Drug Administration…

Endo Health SolutionsEndo PharmaceuticalsGenericsNeurologicalNorth AmericaOpana ERPharmaceuticalRegulation

Back to top